FN1 and breast cancer: Recently, a comparative proteomic analysis of plasma EVs was performed in healthy controls and BC patients undergoing chemotherapy, radiotherapy or after surgery; proteomic analysis of sEV-enriched fractions using a reverse phase protein array revealed a signature of seven proteins that differentiated BC patients from healthy individuals, of which, focal adhesion kinase (FAK) and fibronectin displayed high diagnostic accuracy.